Home/Filings/4/0001144204-10-021793
4//SEC Filing

Fonstein Michael 4

Accession 0001144204-10-021793

CIK 0001318641other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 7:24 PM ET

Size

27.2 KB

Accession

0001144204-10-021793

Insider Transaction Report

Form 4
Period: 2010-04-22
Fonstein Michael
DirectorCEO, President
Transactions
  • Sale

    Common Stock

    2010-04-22$4.00/sh100$4011,270,200 total
  • Sale

    Common Stock

    2010-04-22$3.94/sh400$1,5761,269,500 total
  • Sale

    Common Stock

    2010-04-22$4.00/sh100$4001,268,600 total
  • Sale

    Common Stock

    2010-04-22$3.94/sh100$3941,267,500 total
  • Sale

    Common Stock

    2010-04-22$3.96/sh666$2,6371,266,200 total
  • Sale

    Common Stock

    2010-04-22$3.89/sh600$2,3341,270,600 total
  • Sale

    Common Stock

    2010-04-22$3.92/sh100$3921,270,500 total
  • Sale

    Common Stock

    2010-04-22$3.97/sh200$7941,270,300 total
  • Sale

    Common Stock

    2010-04-22$4.01/sh100$4011,270,100 total
  • Sale

    Common Stock

    2010-04-22$3.91/sh200$7821,269,900 total
  • Sale

    Common Stock

    2010-04-22$3.95/sh600$2,3701,268,900 total
  • Sale

    Common Stock

    2010-04-22$3.99/sh200$7981,268,700 total
  • Sale

    Common Stock

    2010-04-22$3.98/sh900$3,5821,267,700 total
  • Sale

    Common Stock

    2010-04-22$3.96/sh100$3971,267,600 total
  • Sale

    Common Stock

    2010-04-22$3.93/sh634$2,4921,266,866 total
Holdings
  • Employee Stock Options (Right to Buy)

    Exercise: $8.36From: 2007-04-06Exp: 2017-04-05Common Stock (37,500 underlying)
    37,500
  • Employee Stock Options (Right to Buy)

    Exercise: $4.00From: 2008-02-04Exp: 2018-02-03Common Stock (137,250 underlying)
    174,750
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.4% of the reporting person's 1,311,200 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 4.6% of the reporting person's shares held prior to adoption of the plan.

Documents

1 file

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001369806

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 7:24 PM ET
Size
27.2 KB